Meeting
2019 ASCO Annual Meeting
Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).
Authors
Milind M. Javle
University of Texas MD Anderson Cancer Center, Houston, TX
Milind M. Javle , Karthikeyan Murugesan , Rachna T. Shroff , Mitesh J. Borad , Reham Abdel-Wahab , Alexa Betzig Schrock , Jon Chung , Lipika Goyal , Garrett M. Frampton , Robin Kate Kelley , Vincent A. Miller , Jeffrey S. Ross , Tanios S. Bekaii-Saab , Siraj Mahamed Ali , Lee A. Albacker
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Hepatobiliary Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4087)
DOI
10.1200/JCO.2019.37.15_suppl.4087
Abstract #
4087
Poster Bd #
192
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
Expanding the use of targeted therapy for urothelial bladder cancer (UBC): Non-FGFR3 receptor tyrosine kinase (RTK) gene rearrangements (ReAr) and fusions (fus).
First Author: Andrea Necchi
Poster
2014 Gastrointestinal Cancers Symposium
Next-generation sequencing yields promising targets in advanced cholangiocarcinoma (CCA).
First Author: Rachna T. Shroff
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco
Poster
2019 ASCO Annual Meeting
Comprehensive genomic profiling in FIGHT-202 reveals the landscape of actionable alterations in advanced cholangiocarcinoma.
First Author: Ian M. Silverman